The potential of statins as part of anti-cancer treatment.
about
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cellsStatins for preventing colorectal adenoma and carcinomaStatins and fibrates for preventing melanomaTreatment of Cancer Pain by Targeting CytokinesStatin use and association with colorectal cancer survival and risk: case control study with prescription data linkage.Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and NeckStatin use and cancer risk: an epidemiologic review.Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells.The evidence on trial: cholesterol lowering and cancer.The prince and the pauper. A tale of anticancer targeted agents.Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells.Statins and risk of breast cancer recurrence.Prognostic Significance of Statin Use in Colorectal Cancer: A Systematic Review and Meta-Analysis.Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.Cytotoxic evaluation of doxorubicin in combination with simvastatin against human cancer cells.Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.Simvastatin impairs murine melanoma growth.On the factors modulating the effect of statins on malignant cell proliferation.Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo modelsTargeting activated Rho proteins: a new approach for treatment of HPV and other virus-related cancers?Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy.Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity.Validated LC-MS/MS method for simultaneous determination of SIM and its acid form in human plasma and cell lysate: Pharmacokinetic application.Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients.
P2860
Q21093314-0D68677F-A773-4794-B6CC-65489A06A336Q24194802-97F18F6B-9689-4EE9-B7C7-C713D135DE2FQ24245521-50C6D8D6-CAEE-452E-90BE-7C0158D6CDC1Q26779917-9C1A6E5D-B19D-4043-AFB9-7F7F24332F8DQ30574356-D6FC9416-01F9-4D3F-87B0-42F7CCF9E79EQ34369305-2A292571-CDB3-4589-9EB2-2E37AD383219Q36508082-F5044DEB-D725-44A9-81DE-CB8D7EEB6CB8Q36913097-56A712A3-BA63-45BE-8A5C-705C7A7FDBF3Q36982051-6D6E6440-6A99-49F8-B13C-813314528F11Q37042365-5CD6DA7E-B34D-42E4-9262-FAEF35FE8AC3Q37332635-843D0D6A-FB24-4C26-BBC3-8A6D3A052354Q37407449-D7922F7A-8566-4EA2-A5F1-383CFB3EF076Q38536886-F7E5F5CA-07E8-41DD-BB76-FFAC2C20EEA4Q38723341-499C4649-C566-49E1-93B2-33D254D43AD5Q38849103-F57AF43C-A088-4EB4-B0E8-642065C8BF82Q39238333-02D291EB-50A4-4444-9493-81EB62569318Q39429983-70C06FDF-FE1F-437A-A506-152C2B1D9F2EQ39619441-71C73067-FB12-41CA-B776-88F0132A2204Q40101041-E1F94F77-229C-4B1F-AA42-7E2A082C2966Q40148673-96F0F824-BCF8-4AE0-A0E1-DE943F125197Q41951864-B8A02A33-9E4B-46F8-B92C-B0381054FC13Q45364512-221169B0-D097-4020-BCC1-5DF4ABFB096FQ46276263-0C748E14-BEE4-42A2-8953-33720AA7F404Q46686112-90FD41F0-A875-4338-9B5F-2069300B58BEQ49418559-66A3F34F-59EF-4454-8416-C4CF5ECC7601Q52868660-E533B2CA-C4B3-4632-AC72-EDCBAA93352CQ53233606-C15A965A-A33B-4461-83C1-B6AB0217E191Q54692331-520AC498-084F-41CF-85D0-E0C02BD83004
P2860
The potential of statins as part of anti-cancer treatment.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The potential of statins as part of anti-cancer treatment.
@ast
The potential of statins as part of anti-cancer treatment.
@en
type
label
The potential of statins as part of anti-cancer treatment.
@ast
The potential of statins as part of anti-cancer treatment.
@en
prefLabel
The potential of statins as part of anti-cancer treatment.
@ast
The potential of statins as part of anti-cancer treatment.
@en
P2093
P1476
The potential of statins as part of anti-cancer treatment.
@en
P2093
André S Th Planting
Ate van der Gaast
Gerrit Stoter
Jaap Verweij
Stefan Sleijfer
P304
P356
10.1016/J.EJCA.2004.12.009
P577
2005-01-11T00:00:00Z